RxDoctor Payments Data

Denise Workman, DO

Family Medicine · Cleveland, GANPI 1780625293

Payments from drug & device makers

$1,437in general payments, 2019–2025

Across 84 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$412
  • AbbVie$273
  • Lilly USA, LLC$113
  • Pfizer$80
  • GSK$74
  • Takeda Pharmaceuticals U.S.A., Inc.$74
  • plus $411 from 15 others

What the payments were for

  • Food & beverage$1,39697%
  • Education$413%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,437 in reported general payments places this provider in the 65th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$89,174
Medicare patients
142
Services billed
1,441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide108$167,190
MounjaroTirzepatide116$143,488
EliquisApixaban131$115,389
TrulicityDulaglutide65$90,797
Trelegy ElliptaFluticasone/Umeclidin/Vilanter91$89,774
VraylarCariprazine Hcl32$48,729
Repatha SureclickEvolocumab61$43,083
ProliaDenosumab23$40,009
Breo ElliptaFluticasone/Vilanterol61$39,980
Xtampza ErOxycodone Myristate36$37,708
RybelsusSemaglutide17$32,789
MyrbetriqMirabegron42$32,233
TymlosAbaloparatide11$29,186
XareltoRivaroxaban12$21,470
LinzessLinaclotide34$21,262

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$113$234,285181 claims
Novo NordiskOzempic, Rybelsus$55$199,979125 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$74$138,591170 claims
PfizerEliquis$80$115,389131 claims
AbbVieVraylar, Linzess$273$69,99166 claims
AmgenProlia$412$40,00923 claims
Boehringer IngelheimTradjenta, Jardiance$23$21,72625 claims
AstraZenecaFarxiga, Symbicort$16$21,40825 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Cleveland

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →